The global ophthalmic packaging market size is expected to reach USD 20.3 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at an 8.4% CAGR from 2023 to 2030. The increasing global burden of ocular conditions and a growing number of ophthalmic clinics, hospitals, and ambulatory care centers are the factors driving the market growth. Additionally, the frequent introduction of new drug delivery systems and high demand for advanced packaging solutions is expected to fuel the market during the forecast period.
Increasing healthcare expenditure and rising disposable income are some of the prominent factors that are expected to drive a lot of patients towards advanced ophthalmic care. Furthermore, the growing number of advanced healthcare facilities such as eye hospitals and ophthalmic clinics across several regions and increasing awareness about preventive care, ocular disorders, and self-medications are some of the factors expected to aid the market growth.
The increasing geriatric population coupled with age-related ocular disorders is expected to increase the demand for ophthalmic products. Furthermore, the improving reimbursement policies for ocular surgeries including cataract & eye implants, and increasing awareness about ocular disorders and treatment options is expected to drive the market growth.
Government and non-government initiatives such as ocular screening programs and national healthcare programs are expected to increase the accessibility to ophthalmic healthcare. Furthermore, the initiatives such as an “economical free trade zone” & reducing approval time for the establishment of facilities will contribute to the establishment of new ophthalmic manufacturing facilities that are expected to increase the demand for the packaging materials over the forecast period.
Request a free sample copy or view report summary: Ophthalmic Packaging Market Report
Multiple-dose ophthalmic packages held the largest market share in 2022 and are expected to grow at a significant rate over the forecast period. Increasing usage of multiple-dose packaging in OTC preparations coupled with the growing prevalence of common ocular disorders such as red eyes, dry eyes, and conjunctivitis are the major factors expected to drive the growth.
Based on material, plastics packaging material accounted for the largest share and is expected to grow at a significant rate over the forecast period. Low-density polyethylene (LDP) is the most preferred used resin due to its advantages such as flexibility, compatibility, affordability, and safety.
Based on type the ophthalmic packaging market is segmented into prescription and over-the-counter (OTC) products. The prescription type segment held the largest share in 2022 and is expected to grow at a significant rate over the forecast period.
North America held around 35.4% of the global ophthalmic packaging material market in 2022. Developed healthcare infrastructure, rising aging population, the prevalence of eye disorders, and the presence of stringent regulatory bodies are the factors contributing to the significant share.
Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, with the presence of several small and large-scale ophthalmic manufacturing plants and large unmet healthcare needs.
Grand View Research has segmented the global ophthalmic packaging market based on dose, material, type, and region:
Ophthalmic Packaging Dose Outlook (Revenue, USD Million, 2018 - 2030)
Single dose
Multi dose
Ophthalmic Packaging Material Outlook (Revenue, USD Million, 2018 - 2030)
Glass
Plastic
Others
Ophthalmic Packaging Type Outlook (Revenue, USD Million, 2018 - 2030)
OTC
Prescription
Ophthalmic Packaging Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
List of Key Players of Ophthalmic Packaging Market
Amcor Ltd.
West Pharmaceutical Service Inc.
Gerresheimer AG
BD
Schott AG
Aptar Group
Kuwait
"The quality of research they have done for us has been excellent..."